Please note: The information displayed on this page might be outdated.
iOx Therapeutics: Subsidiary of Portage Biotech (seed investor in Biohaven). Launched by Ludwig Cancer Research & University of Oxford. Developing multiple synthetic lipid compounds discovered by research team led by Professor Vincenzo Cerundolo; compounds activate invariant natural killer T-cells. Launching first clinical trial in partnership with UK Medicines and Health Products Regulatory Agency & headed by Professor Mark Middleton (Oxford)
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Disease Space
Immuno-Oncology
Listing
Private
Website:
Address:
Alder Castle
10 Noble Street, 5th floor
London, EC2V 7QJ
United Kingdom

Company Participants at Boston Private Company Showcase

  • Ian B Walters, MD, MBA, CEO and Director

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.